Our pharmaceutical systems are broken, and only fundamental reform can ensure universal access to safer, more innovative, and more affordable drugs
By Adam Gaffney, instructor in medicine 1, Joel Lexchin professor emeritus 2, US, Canadian Pharmaceutical Policy Reform Working Group
BMJ, Analysis, May 2018
To read the full proposal, see below or visit the BMJ website.
To access our economic analysis and supplemental materials, click here.
To read PNHP’s press release, click here.
To read and view media coverage of the proposal, click here.
Click on each section to see text.
Author credentials: 1. Department of Medicine, Cambridge Hospital/Harvard Medical School, Cambridge, MA 02139, USA; 2. School of Health Policy and Management, York University, Toronto, Ontario, Canada